Role of capecitabine in treating metastatic colorectal cancer in Chinese patients

The China Food and Drug Administration approved the use of capecitabine in patients with metastatic colorectal cancer (mCRC) in 2004. This paper reviews the available information of capecitabine in Chinese patients with mCRC, focusing on its effectiveness and safety against mCRC. Identification of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Wang, Feng-Hua, Bai, Long, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979786/
https://www.ncbi.nlm.nih.gov/pubmed/24729715
http://dx.doi.org/10.2147/OTT.S38843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979786/
https://www.ncbi.nlm.nih.gov/pubmed/24729715
http://dx.doi.org/10.2147/OTT.S38843

Ejemplares similares